Conference Coverage

ESPE 2016

12 September 2016
The final day of the 2016 ESPE conference featured more original research communications, symposia and the final two plenary lectures. Long-acting growth hormone: a crowded field? Long-acting growth hormone is getting ever closer to the clinic, with one late-breaking trial plus several presentations in one of the morning’s free communication... Read More
11 September 2016
The second day of ESPE saw the first of the free communication sessions, with researchers presenting their latest findings. A first-line medical option for acromegaly In a well-attended session on pituitary research, Cecile Thomas-Teinturier (Hôpital de Bicétre, Paris, France) reported that pegvisomant treatment produced “drastic decreases” in the... Read More
10 September 2016
Saturday 10th September The 2016 European Society of Paediatric Endocrinology (ESPE) conference kicked off this morning with the ESPE Working Groups, covering gynaecology, diabetes technology and therapeutics, Turner syndrome, bone and growth plate, and disorders of sexual development. Exploring Turner syndrome The Turner syndrome... Read More

IMAGE: Insights into MAnaging Growth for Endocrine nurses

Symposium Faculty members reflect on the event.

Programme director Professor Martin Savage gives an overview of the symposium content.

06 February 2015
Meeting report now available featuring highlights of key talks, video interviews and reflections on the event – Download now

ESPE 2014

Professor Jovanna Dahlgren talks to medwireNewsFocus about her decade of clinical experience using prediction models to optimise growth hormone treatment in prepubertal children.

Professor Moshe Phillip talks to medwireNews Focus about a wireless fully automated closed-loop system for the control of diabetes, and how it provides a potent tool for lowering the rate of nocturnal hypoglycaemia and improving overall glucose control.

Professor Krishna Chatterjee talks to medwireNews Focus about new forms of thyroid resistance that are particularly relevant to paediatric endocrine practice, and how the identification of these disorders could impact on future therapy decisions. To contact the team about rare clinical case diagnoses seen in your own practice, please email Professor Chatterjee at kkc1@... Read more

20 September 2014
The final day of ESPE 2014 shone the spotlight on obesity, starting with the first of the day’s plenary lectures given by Donal O’Shea (St Vincent’s University Hospital, Dublin, Ireland). Prevention better than cure O’Shea described obesity as “an epidemic that has come disguised as progress and development”. He likened the current state of... Read More
19 September 2014
The second day of ESPE 2014 saw the first of the new research communications, with sessions including adrenal, diabetes, growth and neuroendocrinology. Transforming life quality in HPP Another of these sessions covered bone and mineral research, and included a 3-year update on 11 infants and children with hypophosphatasia (HPP) who were treated with... Read More
18 September 2014
Opening the morning’s Working Group Session on diabetes technology and therapeutics, Moshe Phillip (Schneider Children's Medical Center of Israel, Petah Tikva) noted that there has been “traditionally little focus on diabetes” at ESPE meetings. Around 50 people were expected for this session, but it was eventually attended by more than 300, which session... Read More